Monte Rosa Therapeutics, Inc.GLUENASDAQ
Loading
P/FCF Ratio Over TimeContracting
Percentile Rank17
Studio
Year-over-Year Change

Price to free cash flow ratio

Latest
-47.37
↓ 55% vs avg
Percentile
P17
Within normal range
Streak
1 yr
Consecutive declineContracting
Average
-30.60
Historical baseline
PeriodValueYoY Change
2025-47.37-451.0%
202413.50+392.1%
2023-4.62-35.5%
2022-3.41+75.2%
2021-13.75+61.0%
2020-35.25+71.4%
2019-123.31-